Church & Dwight (NYSE:CHD – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided EPS guidance of 3.420-3.420 for the period, compared to the consensus EPS estimate of 3.430. The company issued revenue guidance of $6.1 billion-$6.1 billion, compared to the consensus revenue estimate of $6.1 billion. Church & Dwight also updated its Q4 guidance to $0.76 EPS.
Wall Street Analysts Forecast Growth
CHD has been the subject of several research reports. Morgan Stanley downgraded Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 price objective for the company. in a research report on Monday, September 9th. Evercore ISI reduced their price objective on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research report on Monday, August 5th. Piper Sandler assumed coverage on Church & Dwight in a research report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price objective for the company. TD Cowen boosted their target price on shares of Church & Dwight from $114.00 to $117.00 and gave the company a “buy” rating in a research note on Monday. Finally, Barclays raised their price target on shares of Church & Dwight from $82.00 to $86.00 and gave the stock an “underweight” rating in a research note on Friday, October 11th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Church & Dwight presently has a consensus rating of “Hold” and a consensus target price of $108.10.
Get Our Latest Analysis on CHD
Church & Dwight Trading Down 1.7 %
Church & Dwight (NYSE:CHD – Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period last year, the business posted $0.74 EPS. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. Equities research analysts forecast that Church & Dwight will post 3.43 EPS for the current fiscal year.
Church & Dwight Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Friday, November 15th will be paid a dividend of $0.2838 per share. The ex-dividend date is Friday, November 15th. This represents a $1.14 annualized dividend and a yield of 1.10%. Church & Dwight’s dividend payout ratio is currently 50.67%.
Church & Dwight Company Profile
Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.
See Also
- Five stocks we like better than Church & Dwight
- Consumer Staples Stocks, Explained
- Intel: Is Now the Time to Be Brave?Â
- How to Find Undervalued Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Differences Between Momentum Investing and Long Term Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Church & Dwight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Church & Dwight and related companies with MarketBeat.com's FREE daily email newsletter.